CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma

by Quintás-Cardama, Alfonso
Published in Oncotarget (2018)

Molecular biology of bcr-abl1–positive chronic myeloid leukemia

by Quintás-Cardama, Alfonso, Cortes, Jorge
Published 2009

Bullet ‘Manicure’: Does Lead Prevent Hydroxyurea-induced Cutaneous Toxicity?

by Falchi, Lorenzo, Quintás-Cardama, Alfonso
Published in Jpn J Clin Oncol (2014)

MOLECULAR PATHWAYS: JAK/STAT PATHWAY: MUTATIONS, INHIBITORS, AND RESISTANCE

by Quintás-Cardama, Alfonso, Verstovsek, Srdan
Published in Clin Cancer Res (2013)

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans

by Pant, Vinod, Quintás-Cardama, Alfonso, Lozano, Guillermina
Published 2012

ADVANCES AND CONTROVERSIES IN THE DIAGNOSIS, PATHOGENESIS, AND TREATMENT OF SYSTEMIC MASTOCYTOSIS

by Quintás-Cardama, Alfonso, Jain, Nitin, Verstovsek, Srdan
Published in Cancer (2011)

The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome

by Larsson, Connie A., Cote, Gilbert, Quintás-Cardama, Alfonso
Published 2013

Investigational Immunotherapeutics for B-Cell Malignancies

by Quintás-Cardama, Alfonso, Wierda, William, O'Brien, Susan
Published in J Clin Oncol (2010)

Monitoring Molecular Response in Chronic Myeloid Leukemia

by Cortes, Jorge, Quintás-Cardama, Alfonso, Kantarjian, Hagop M.
Published in Cancer (2010)

Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia

by Quintás-Cardama, Alfonso, Han, Xin, Kantarjian, Hagop, Cortes, Jorge
Published 2009

Early Cytogenetic and Molecular Response During First-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase: Long-Term Implications

by Quintás-Cardama, Alfonso, Cortes, Jorgé E., Kantarjian, Hagop M.
Published 2011

p53 pathway dysfunction in AML: beyond TP53 mutations

by Post, Sean M., Kornblau, Steven M., Quintás-Cardama, Alfonso
Published in Oncotarget (2017)

Prognostic Impact of the MDM2(SNP309) Allele in Leukemia and Lymphoma

by Post, Sean M., Pant, Vinod, Abbas, Hussein, Quintás-Cardama, Alfonso
Published 2010

Evolution of Therapies for Chronic Myelogenous Leukemia

by Santos, Fabio P S, Kantarjian, Hagop, Quintás-Cardama, Alfonso, Cortes, Jorge
Published 2011

THE RISE AND FALL OF GAKEKEEPER MUTATIONS? THE BCR-ABL1(T315I) PARADIGM

by Gibbons, Don L., Pricl, Sabrina, Cortes, Jorge, Quintás-Cardama, Alfonso
Published in Cancer (2011)

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability

by Pant, Vinod, Xiong, Shunbin, Iwakuma, Tomoo, Quintás-Cardama, Alfonso, Lozano, Guillermina
Published 2011

Prognostic Model to Identify Patients With Myelofibrosis at the Highest Risk of Transformation to Acute Myeloid Leukemia

by Quintás-Cardama, Alfonso, Kantarjian, Hagop, Pierce, Sherry, Cortes, Jorge, Verstovsek, Srdan
Published 2013

Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis

by Quintás-Cardama, Alfonso, Sever, Matjaz, Cortes, Jorge, Kantarjian, Hagop, Verstovsek, Srdan
Published in Leuk Lymphoma (2013)

SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH POLYCYTHEMIA VERA

by Sever, Matjaz, Quintás-Cardama, Alfonso, Pierce, Sherry, Zhou, Lingsha, Kantarjian, Hagop, Verstovsek, Srdan
Published 2013

PREDICTING OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AT ANY TIME DURING TYROSINE KINASE INHIBITOR THERAPY

by Quintás-Cardama, Alfonso, Choi, Sangbum, Kantarjian, Hagop, Jabbour, Elias, Huang, Xuelin, Cortes, Jorge
Published 2014